课题基金 / 基金详情

ANTIBODIES AS CATALYSTS

ANTIBODIES AS CATALYSTS
抗体作为催化剂
批准号:
2770945
负责人:
ROBYN L STANFIELD
金额:
$34.19万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-04-01 至 2000-08-31

项目摘要

项目成果

ROBYN L STANFIELD的其他基金

相似基金

相关文献

中文摘要
翻译
这是一个关于我们资助的更新的建议, 通过对酶催化作用的研究, 抗体的催化抗体技术代表了 创造新酶的通用策略, 几年来:针对过渡态类似物产生的抗体, 催化了超过50种化学转化, 加速和高选择性。这一领域当前的挑战是 是产生具有更高化学效率的催化剂。的 这项建议的具体目标是从三个方面解决这一问题。第一、 四种代表性抗体催化剂的结构和机理将 详细调查。这些试剂催化克莱森重排, 双分子Diels-Alder环加成反应, 脱羧和碱依赖性消除反应。 他们的研究将有助于我们对基本原理的理解 包括过渡态互补性的作用, 邻近效应、去溶剂化和化学催化, 与产生更活性的催化剂相关的信息。二是通过 改进过渡态模拟设计, 更有效的筛选技术,我们希望优化策略 已经被开发用来产生个体催化抗体。 第三,将研究遗传选择作为一种工具, 第一代催化抗体的活性。通过表征 随着抗体变得更加活跃, 获得对分子功能进化的基本见解。我们 预计在该项目中吸取的经验教训将导致 设计高活性人工晶体的一般策略 酶在化学、生物学和医学中具有广泛的应用性。 具体地说,我们希望创造实用的抗体催化剂, 维生素B6的合成和磷酸单酯的水解。
英文摘要
This is a proposal for renewal of our grant supporting work on imitating and understanding enzymic catalysis through the study of catalytic antibodies. Catalytic antibody technology represents one of the most versatile strategies for creating new enzymes to emerge in the last several years: antibodies raised against transition state analogs have catalyzed more than 50 chemical transformations with significant rate accelerations and high selectivity. The immediate challenge in this field is to generate catalysts with even greater chemical efficiency. The specific aims of this proposal address this issue in three ways. First, the structure and mechanism of four representative antibody catalysts will be investigated in detail. These agents catalyze a Claisen rearrangement, a bimolecular Diels-Alder cycloaddition, a medium-sensitive decarboxylation, and a base-dependent elimination reaction, respectively. Their study will contribute to our understanding of the basic principles of catalysis, including the roles of transition state complementarity, proximity effects, desolvation, and chemical catalysis, providing information relevant to the creation of more active catalysts. Second, by refining transition state analog design and by developing and implementing more effective screening technologies we hope to optimize the strategies that have been developed to generate individual catalytic antibodies. Third, genetic selection will be investigated as a tool for augmenting the activity of first-generation catalytic antibodies. By characterizing the genetic changes that accumulate as the antibody becomes more active we may gain fundamental insight into the evolution of molecular function. We anticipate that the lessons learned in this project will lead to the elaboration of general strategies for designing highly active artificial enzymes of wide applicability in chemistry, biology, and medicine. Specifically, we hope to create practical antibody catalysts for the synthesis of vitamin B6 and for the hydrolysis of phosphate monoesters.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antigenic structures of HCV envelope glycoproteins (Env)
  • 批准号:
    10428300
  • 项目类别:
  • 资助金额:
    $63.9万
  • 财政年份:
    2022
  • 负责人:
    ROBYN L STANFIELD
  • 依托单位:
Antigenic structures of HCV envelope glycoproteins (Env)
  • 批准号:
    10557877
  • 项目类别:
  • 资助金额:
    $62.66万
  • 财政年份:
    2022
  • 负责人:
    ROBYN L STANFIELD
  • 依托单位:
海外基金